Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharathi Vennapusa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Molecular Signaling|January 17, 2007
Differential partitioning of Galphai1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cellsHemant K Parekh, Mahesha Adikari, Bharathi Vennapusa
Breast Cancer (Tokyo, Japan)|May 26, 2009
C-kit-positive gastric metastasis of lobular carcinoma of the breast masquerading as gastrointestinal stromal tumorBharathi Vennapusa, Sarah A Oman, Gulshan Parasher, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|August 10, 2012
Unique presentation of Meckel diverticulum in the form of cocoon managed successfully by laparoscopic surgeryVennapusa Amar, Karuppusamy Sendhil Kumar, Panchangam Ramakanth Bhargav, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 13, 2011
CD10 immunoreactivity in sarcomatoid carcinomas: comparison with true sarcomasBharathi Vennapusa, Edgar G Fischer, Mark R Wick, et al.
American Journal of Clinical Pathology|February 26, 2011
Erythrocyte sedimentation rate (ESR) measured by the Streck ESR-Auto Plus is higher than with the Sediplast Westergren method: a validation studyBharathi Vennapusa, Laura De La Cruz, Hemangini Shah, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2020
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast CancerYijin Li, Bharathi Vennapusa, Ching-Wei Chang, et al.
Diagnostic Pathology|May 19, 2016
Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3NJacquelyn Smith, Mark D Robida, Krista Acosta, et al.
Biomedicines|October 29, 2025
Development of a Novel IHC Assay for PD-L1 Detection in Non-Small Cell Lung CancerFaye Willett, Marie MacLennan, Sihem Khelifa, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Molecular Signaling|January 17, 2007
Differential partitioning of Galphai1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cellsHemant K Parekh, Mahesha Adikari, Bharathi Vennapusa
Breast Cancer (Tokyo, Japan)|May 26, 2009
C-kit-positive gastric metastasis of lobular carcinoma of the breast masquerading as gastrointestinal stromal tumorBharathi Vennapusa, Sarah A Oman, Gulshan Parasher, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|August 10, 2012
Unique presentation of Meckel diverticulum in the form of cocoon managed successfully by laparoscopic surgeryVennapusa Amar, Karuppusamy Sendhil Kumar, Panchangam Ramakanth Bhargav, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 13, 2011
CD10 immunoreactivity in sarcomatoid carcinomas: comparison with true sarcomasBharathi Vennapusa, Edgar G Fischer, Mark R Wick, et al.
American Journal of Clinical Pathology|February 26, 2011
Erythrocyte sedimentation rate (ESR) measured by the Streck ESR-Auto Plus is higher than with the Sediplast Westergren method: a validation studyBharathi Vennapusa, Laura De La Cruz, Hemangini Shah, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2020
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast CancerYijin Li, Bharathi Vennapusa, Ching-Wei Chang, et al.
Diagnostic Pathology|May 19, 2016
Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3NJacquelyn Smith, Mark D Robida, Krista Acosta, et al.
Biomedicines|October 29, 2025
Development of a Novel IHC Assay for PD-L1 Detection in Non-Small Cell Lung CancerFaye Willett, Marie MacLennan, Sihem Khelifa, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Pageof 2